These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 409319)

  • 1. Treatment of tuberculosis in alcoholic patients.
    Edsall JR; Awe RJ; Bunyan SB; Hackney RL; Iseman MD; Reagan WP
    Am Rev Respir Dis; 1977 Sep; 116(3):559-61. PubMed ID: 409319
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months.
    Menzies D; Dion MJ; Rabinovitch B; Mannix S; Brassard P; Schwartzman K
    Am J Respir Crit Care Med; 2004 Aug; 170(4):445-9. PubMed ID: 15172892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
    Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
    Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should the dose of antituberculosis drugs be reduced in patients with liver disease?
    Pillans PI
    S Afr Med J; 1985 Apr; 67(14):527. PubMed ID: 3992375
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of tuberculosis in alcoholic patients.
    Sexias FA
    Am Rev Respir Dis; 1977 Sep; 116(3):548-9. PubMed ID: 900643
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial treatment of tuberculosis with streptomycin and isoniazid combined with either aminosalyl or rifampicin.
    Engbaek HC; Larsen SO; Rasmussen KN; Vergmann B
    Scand J Respir Dis; 1973; 54(2):83-91. PubMed ID: 4122479
    [No Abstract]   [Full Text] [Related]  

  • 10. Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens.
    Lambert LA; Ijaz K; Navin TR
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):230; author reply 230-1. PubMed ID: 15732748
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
    Small PM; Schecter GF; Goodman PC; Sande MA; Chaisson RE; Hopewell PC
    N Engl J Med; 1991 Jan; 324(5):289-94. PubMed ID: 1898769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide].
    Brändli O; Dreher D; Morger D
    Schweiz Med Wochenschr; 1993 Jun; 123(25):1300-6. PubMed ID: 8341998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [INH and rifampicin dosage at the beginning of tuberculosis treatment].
    Peltier G; Frey N; Legrand M; Teyssier L
    Nouv Presse Med; 1977 Sep; 6(30):2692. PubMed ID: 909763
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of latent tuberculosis infection.
    Lepage P
    N Engl J Med; 2003 Mar; 348(13):1292-3; author reply 1292-3. PubMed ID: 12661577
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tuberculosis treatment in 1992].
    Radermecker M
    Rev Med Liege; 1993 Mar; 48(3):143-6. PubMed ID: 8469858
    [No Abstract]   [Full Text] [Related]  

  • 16. Rationale and experimental data in support of the use of a fixed-triple combination of isoniazid, rifampicin and pyrazinamide in the chemotherapy of tuberculosis.
    Acocella G
    G Ital Chemioter; 1987; 34(1-3):3-5. PubMed ID: 3504412
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rifomycin in continuous and intermittent combined treatment of experimental tuberculosis in mice].
    Grumbach F
    Acta Tuberc Pneumol Belg; 1969; 60(3):390-6. PubMed ID: 5371670
    [No Abstract]   [Full Text] [Related]  

  • 18. [New drugs in the treatment of primary tuberculosis].
    Gerbeaux J; Hanoteau J
    Ann Pediatr (Paris); 1970 Oct; 17(10):638-43. PubMed ID: 5475417
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of isoniazid and rifampicin regimens on the liver of tuberculosis patients].
    Pilheu JA; De Salvo MC; Barcat JA
    Medicina (B Aires); 1979; 39(3):298-304. PubMed ID: 514051
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection.
    Holland DP; Hamilton CD; Weintrob AC; Engemann JJ; Fortenberry ER; Peloquin CA; Stout JE
    Pharmacotherapy; 2009 May; 29(5):503-10. PubMed ID: 19397460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.